Charles R. Kummeth Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 3 hours ago
Charles R. Kummeth has an estimated net worth of at least $79.0 million*, as of May 7, 2025. They own 1.3 million shares of TECH stock. They have sold 105,405 shares of TECH stock since 2021, for an estimated $17.9 million.
Charles R. Kummeth $TECH SEC Form 4 Insider Trading
Charles R. Kummeth has filed a total of 11 insider trades in $TECH since 2021. Their most recent trade was a sale of 80,000 shares, made on Jul 21, 2023. Their largest trade was a sale of 80,000 shares, made on Jul 21, 2023. We estimate that they now own 1.3 million shares of $TECH, worth an estimated $61.1 million.
Insider Trading at $TECH
There have been a total of 82 insider trades reported at $TECH since 2021, with 300 shares purchased and 257,640 shares sold. The most active insider traders in $TECH stock have been James Hippel, Charles R. Kummeth, and Norman David Eansor. The most recent trade was a sale of 1,860 shares reported by Amy E. Herr (None), made on Feb 14, 2025.
History of Insider Stock Trades by Charles R. Kummeth
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
QSI
|
Purchase | 31,100 | Aug 12, 2024 | Aug. 13, 2024, 6:01 a.m. |
|
QSI
|
Purchase | 138,900 | Aug 09, 2024 | Aug. 13, 2024, 6:01 a.m. |
TECH
|
Sale | 80,000 | Jul 21, 2023 | July 25, 2023, 5:27 p.m. |
|
TECH
|
Sale | 322 | Jun 07, 2023 | June 9, 2023, 4:07 p.m. |
|
TECH
|
Sale | 5,104 | Jun 07, 2022 | June 8, 2022, 8 p.m. |
|
TECH
|
Sale | 326 | Jun 18, 2021 | June 20, 2021, 8 p.m. |
|
TECH
|
Sale | 6,732 | Jun 17, 2021 | June 20, 2021, 8 p.m. |
|
TECH
|
Sale | 1,698 | Jun 17, 2021 | June 20, 2021, 8 p.m. |
|
TECH
|
Sale | 1,050 | Jun 17, 2021 | June 20, 2021, 8 p.m. |
|
TECH
|
Sale | 109 | Jun 17, 2021 | June 20, 2021, 8 p.m. |
|
TECH
|
Sale | 2,583 | Jun 18, 2021 | June 20, 2021, 8 p.m. |
|
TECH
|
Sale | 349 | Jun 14, 2021 | June 15, 2021, 8 p.m. |
|
TECH
|
Sale | 7,132 | Jun 14, 2021 | June 15, 2021, 8 p.m. |
$TECH Executives and Stock Owners with Insider Trades
-
James Hippel, Chief Financial Officer
-
Charles R. Kummeth, Chief Executive Officer
-
Norman David Eansor, President-Protein Sciences
-
Kim Kelderman, Pres. Diagnostics & Genom
-
Brenda S. Furlow, SVP - General Counsel
-
Brenda S. Furlow, SVP - GENERAL COUNSEL
-
Kim Kelderman, Chief Executive Officer
-
Charles R. Kummeth, CHIEF EXECUTIVE OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.